Study Name:
CASCADE-LUNG (Cancer Screening Assay using DELFI): A Clinical Validation Study in Lung Cancer
Targeted Disease(s):
Lung Cancer
Purpose of Study:
We are recruiting approximately 15,000 individuals for a large-scale study to help determine the ability of our simple, blood-based screening technology to detect lung cancer accurately and reliably.
Study Dates:
August 1, 2022 - September 30, 2023
Study Location:
Nationwide
Lead Institution:
Thomas Jefferson University
Funding Source:
Delfi Diagnostics
Contact:
Registration phone: 855-457-4816
Registration email: lungcancerscreening@science37.com
ClinicalTrails.gov Identifier:
NCT05306288
